Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
FDA Drug Recall #D-1340-2022 — Class II — June 27, 2022
Recall Summary
| Recall Number | D-1340-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 27, 2022 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Loud Muscle Science |
| Location | Hauppauge, NY |
| Product Type | Drugs |
| Quantity | 1500 10-count tins |
Product Description
Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Reason for Recall
Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.
Distribution Pattern
The product was distributed nationwide in the USA and Canada.
Lot / Code Information
Lot# C07172101, Exp date: 07/2024.
Other Recalls from Loud Muscle Science
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1338-2022 | Class I | Launch Sequence Aphrodisia Capsules, 4-count ti... | Jun 27, 2022 |
| D-1336-2022 | Class I | Launch Sequence Capsules, Dietary Supplement, 6... | Jun 27, 2022 |
| D-1337-2022 | Class I | Launch Sequence Euphoria Capsules, 10- count ti... | Jun 27, 2022 |
| D-1341-2022 | Class II | Launch Sequence Aphrodisia Capsules, 4-count ti... | Jun 27, 2022 |
| D-1339-2022 | Class II | Launch Sequence Capsules, Dietary Supplement, 6... | Jun 27, 2022 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.